“The subjects had antibodies that were 8 times more effective against the virus.”
Moderna said in a statement on June 8 that after testing its latest vaccine, which combines the old formulation and the new protection, it found that Vaccines that are effective in protecting people from higher infection with Omicron strains of coronavirus.
Early Moderna studies show that The newly vaccinated cohort had antibodies that were 8 times more protective against the virus and were able to directly counteract omicrons.
The coronavirus vaccine currently in use around the world continues to be the development of a traditional coronavirus vaccine. There is no vaccine that directly counteracts the new mutations, but overall it can prevent serious illness leading to hospitalization and death.
Virus mutations continue so rapidly that they can circumvent existing vaccines and cause mild, symptomatic infections.
Currently, the US public health agency And the World Health Organization is considering whether to order changes in vaccine formulas for distribution later this year. because it will enter the period of the flu epidemic and will be the period when students in the United States will start the new academic year in September
The CNA news agency pointed out that the most important question at the moment is Where will the changes take place as mutations are constantly changing and new vaccines must be developed to deal with which strains of coronavirus? Because the world has seen that the new Omicron species has been mutated. can quickly become the dominant strain in the outbreak instead of the delta species.
Moderna further stated that The test was a new vaccination test on a sample of 437 people. The safety of the vaccine is similar to that of the current booster vaccine. However, it is unclear how long the new vaccine’s ability to protect people from omicrons will last.
